Catena Biosciences

Catena Biosciences YC 申请

Summer 2021Active

Catena Biosciences 在 Summer 2021 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Summer 2021
行业
HealthcareTherapeutics
团队规模
7
状态
Active
已发布
2021

创始人

  • Marco Lobba
    Marco LobbaFounder
  • Matthew FrancisFounder

Catena Biosciences 做什么

Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.

Catena Biosciences 的 YC 申请,重建版

Y Combinator 申请

Catena Biosciences,Summer 2021 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Catena Biosciences

Describe what your company does in 50 characters or less.

Using protein coupling to build new therapies

What is your company going to make? Please describe your product and what it does or will do.

We built a protein coupling technology that lets us attach any two proteins together through an enzyme that targets tyrosine and cysteine amino acids natively present in the proteins. Unlike traditional methods, we don't engineer each protein extensively or have restrictions on size or complexity. This allows us to rapidly create modular protein therapeutics for oncology, vaccines, inflammatory diseases, and more.

Where do you live now, and where would the company be based after YC?

We live and work in Berkeley, California, and the company would remain based here after YC.

Explain your decision regarding location.

Berkeley has a strong biotech ecosystem and access to academic labs and talent we rely on. We're well situated near collaborators and in a hub of innovation for therapeutics development.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 Catena Biosciences 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 Catena Biosciences 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Catena Biosciences 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

Catena Biosciences 是哪个 YC 批次的?

Catena Biosciences 是 Y Combinator Summer 2021 批次的成员。

谁创立了 Catena Biosciences?

Catena Biosciences 由 Marco Lobba, Matthew Francis 创立。

Catena Biosciences 做什么?

Using protein coupling to build new therapies

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 Catena Biosciences 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 Catena Biosciences